Literature DB >> 29427422

Relative Abundances of Candida albicans and Candida glabrata in In Vitro Coculture Biofilms Impact Biofilm Structure and Formation.

Michelle L Olson1, Arul Jayaraman2, Katy C Kao2.   

Abstract

Candida is a member of the normal human microbiota and often resides on mucosal surfaces such as the oral cavity or the gastrointestinal tract. In addition to their commensality, Candida species can opportunistically become pathogenic if the host microbiota is disrupted or if the host immune system becomes compromised. An important factor for Candida pathogenesis is its ability to form biofilm communities. The two most medically important species-Candida albicans and Candida glabrata-are often coisolated from infection sites, suggesting the importance of Candida coculture biofilms. In this work, we report that biofilm formation of the coculture population depends on the relative ratio of starting cell concentrations of C. albicans and C. glabrata When using a starting ratio of C. albicans to C. glabrata of 1:3, ∼6.5- and ∼2.5-fold increases in biofilm biomass were observed relative to those of a C. albicans monoculture and a C. albicans/C. glabrata ratio of 1:1, respectively. Confocal microscopy analysis revealed the heterogeneity and complex structures composed of long C. albicans hyphae and C. glabrata cell clusters in the coculture biofilms, and reverse transcription-quantitative PCR (qRT-PCR) studies showed increases in the relative expression of the HWP1 and ALS3 adhesion genes in the C. albicans/C. glabrata 1:3 biofilm compared to that in the C. albicans monoculture biofilm. Additionally, only the 1:3 C. albicans/C. glabrata biofilm demonstrated an increased resistance to the antifungal drug caspofungin. Overall, the results suggest that interspecific interactions between these two fungal pathogens increase biofilm formation and virulence-related gene expression in a coculture composition-dependent manner.IMPORTANCECandida albicans and Candida glabrata are often coisolated during infection, and the occurrence of coisolation increases with increasing inflammation, suggesting possible synergistic interactions between the two Candida species in pathogenesis. During the course of an infection, the prevalence of each Candida species may change over time due to differences in metabolism and in the resistance of each species to antifungal therapies. Therefore, it is necessary to understand the dynamics between C. albicans and C. glabrata in coculture to develop better therapeutic strategies against Candida infections. Existing in vitro work has focused on understanding how an equal-part culture of C. albicans and C. glabrata impacts biofilm formation and pathogenesis. What is not understood, and what is investigated in this work, is how the composition of Candida species in coculture impacts overall biofilm formation, virulence gene expression, and the therapeutic treatment of biofilms.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  CLSM; Candida; biofilm; biofilms; coculture; mycobiota

Mesh:

Substances:

Year:  2018        PMID: 29427422      PMCID: PMC5881068          DOI: 10.1128/AEM.02769-17

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  71 in total

1.  Heterogeneous expression of the virulence-related adhesin Epa1 between individual cells and strains of the pathogen Candida glabrata.

Authors:  Samantha C Halliwell; Matthew C A Smith; Philippa Muston; Sara L Holland; Simon V Avery
Journal:  Eukaryot Cell       Date:  2011-12-02

Review 2.  The mycobiota: interactions between commensal fungi and the host immune system.

Authors:  David M Underhill; Iliyan D Iliev
Journal:  Nat Rev Immunol       Date:  2014-06       Impact factor: 53.106

Review 3.  Growth of Candida albicans hyphae.

Authors:  Peter E Sudbery
Journal:  Nat Rev Microbiol       Date:  2011-08-16       Impact factor: 60.633

Review 4.  The indigenous gastrointestinal microflora.

Authors:  R D Berg
Journal:  Trends Microbiol       Date:  1996-11       Impact factor: 17.079

5.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

Authors:  M H Nguyen; J E Peacock; A J Morris; D C Tanner; M L Nguyen; D R Snydman; M M Wagener; M G Rinaldi; V L Yu
Journal:  Am J Med       Date:  1996-06       Impact factor: 4.965

6.  Monitoring ALS1 and ALS3 gene expression during in vitro Candida albicans biofilm formation under continuous flow conditions.

Authors:  Heleen Nailis; Roosmarijn Vandenbroucke; Kelly Tilleman; Dieter Deforce; Hans Nelis; Tom Coenye
Journal:  Mycopathologia       Date:  2008-08-06       Impact factor: 2.574

7.  Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs.

Authors:  Cassandra Moran; Chelsea A Grussemeyer; James R Spalding; Daniel K Benjamin; Shelby D Reed
Journal:  Pediatr Infect Dis J       Date:  2009-05       Impact factor: 2.129

Review 8.  Options for the management of mucosal candidiasis in patients with AIDS and HIV infection.

Authors:  J A Vazquez
Journal:  Pharmacotherapy       Date:  1999-01       Impact factor: 4.705

9.  Multi-species biofilm of Candida albicans and non-Candida albicans Candida species on acrylic substrate.

Authors:  Apurva K Pathak; Sanjay Sharma; Pallavi Shrivastva
Journal:  J Appl Oral Sci       Date:  2012-02       Impact factor: 2.698

10.  The Candida albicans Biofilm Matrix: Composition, Structure and Function.

Authors:  Christopher G Pierce; Taissa Vila; Jesus A Romo; Daniel Montelongo-Jauregui; Gina Wall; Anand Ramasubramanian; Jose L Lopez-Ribot
Journal:  J Fungi (Basel)       Date:  2017-03-08
View more
  7 in total

1.  Rhodotorula sp. and Trichosporon sp. are more Virulent After a Mixed Biofilm.

Authors:  Isabele Carrilho Jarros; Isabella Letícia Esteves Barros; Andressa Prado; Jakeline Luiz Corrêa; Amanda Milene Malacrida; Melyssa Negri; Terezinha Inez Estivalet Svidzinski
Journal:  Mycopathologia       Date:  2021-12-02       Impact factor: 2.574

Review 2.  The Antibiofilm Role of Biotics Family in Vaginal Fungal Infections.

Authors:  Angela Boahen; Leslie Thian Lung Than; Yi-Linn Loke; Shu Yih Chew
Journal:  Front Microbiol       Date:  2022-05-26       Impact factor: 6.064

3.  Polymicrobial Biofilm Dynamics of Multidrug-Resistant Candida albicans and Ampicillin-Resistant Escherichia coli and Antimicrobial Inhibition by Aqueous Garlic Extract.

Authors:  Priya Ashrit; Bindu Sadanandan; Kalidas Shetty; Vijayalakshmi Vaniyamparambath
Journal:  Antibiotics (Basel)       Date:  2022-04-25

4.  A Factor Produced by Kaistia sp. 32K Accelerated the Motility of Methylobacterium sp. ME121.

Authors:  Yoshiaki Usui; Yuu Wakabayashi; Tetsu Shimizu; Yuhei O Tahara; Makoto Miyata; Akira Nakamura; Masahiro Ito
Journal:  Biomolecules       Date:  2020-04-16

Review 5.  The role of Lactobacillus species in the control of Candida via biotrophic interactions.

Authors:  Isabella Zangl; Ildiko-Julia Pap; Christoph Aspöck; Christoph Schüller
Journal:  Microb Cell       Date:  2019-11-25

6.  Sodium houttuyfonate enhances the mono-therapy of fluconazole on oropharyngeal candidiasis (OPC) through HIF-1α/IL-17 axis by inhibiting cAMP mediated filamentation in Candida albicans-Candida glabrata dual biofilms.

Authors:  Mengli Chen; Ting Cheng; Chen Xu; Min Pan; Jiadi Wu; Tianming Wang; Daqiang Wu; Guiming Yan; Changzhong Wang; Jing Shao
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

7.  Insights into the Antimicrobial Activities and Metabolomes of Aquimarina (Flavobacteriaceae, Bacteroidetes) Species from the Rare Marine Biosphere.

Authors:  Sandra Godinho Silva; Patrícia Paula; José Paulo da Silva; Dalila Mil-Homens; Miguel Cacho Teixeira; Arsénio Mendes Fialho; Rodrigo Costa; Tina Keller-Costa
Journal:  Mar Drugs       Date:  2022-06-28       Impact factor: 6.085

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.